相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lu-177-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
Thorsten Derlin et al.
JOURNAL OF NUCLEAR MEDICINE (2023)
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity
Eline A. M. Ruigrok et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Radiolabeled Bombesin Analogs
Rosalba Mansi et al.
CANCERS (2021)
[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes
Berthold A. Nock et al.
CANCERS (2021)
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?
Pinuccia Faviana et al.
FRONTIERS IN ONCOLOGY (2021)
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Ute Hennrich et al.
PHARMACEUTICALS (2021)
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [99mTc]Tc-DB4 and [111In]In-SG4 in Mice Treated with Entresto
Panagiotis Kanellopoulos et al.
PHARMACEUTICS (2020)
Synthesis and Evaluation of 68Ga- and 177Lu-Labeled (R)- vs (S)-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives
Ruiyue Zhao et al.
MOLECULAR PHARMACEUTICS (2020)
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
Martin K. Bakht et al.
ENDOCRINE-RELATED CANCER (2019)
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair
Emmanouil Lymperis et al.
MOLECULES (2019)
Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26
Bogdan Mitran et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin
Emmanouil Lymperis et al.
BIOCONJUGATE CHEMISTRY (2018)
New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation
Berthold A. Nock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor
Surya Ayalasomayajula et al.
CLINICAL PHARMACOKINETICS (2017)
Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26
Bogdan Mitran et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Gastrin-Releasing Peptide Receptor (GRPr) Promotes EMT, Growth, and Invasion in Canine Prostate Cancer
Said M. Elshafae et al.
PROSTATE (2016)
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies
Kristell L. S. Chatalic et al.
THERANOSTICS (2016)
To Serve and Protect: Enzyme Inhibitors as Radiopeptide Escorts Promote Tumor Targeting
Berthold A. Nock et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Detecting ligand interactions with G protein-coupled receptors in real-time on living cells
Bo Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates
Marc Beer et al.
PROSTATE (2012)
Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
Erik Vegt et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites
Karen E. Linder et al.
BIOCONJUGATE CHEMISTRY (2009)
Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides
Rosalba Mansi et al.
CLINICAL CANCER RESEARCH (2009)
Expression of the Gastrin-Releasing Peptide Receptor, the Prostate Stem Cell Antigen and the Prostate-Specific Membrane Antigen in Lymph Node and Bone Metastases of Prostate Cancer
Hildo J. K. Ananias et al.
PROSTATE (2009)
Bombesin receptor antagonists may be preferable to agonists for tumor targeting
Renzo Cescato et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Gastric secretion
ML Schubert
CURRENT OPINION IN GASTROENTEROLOGY (2002)
Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist
P Hildebrand et al.
GUT (2001)
The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter
DM Xiao et al.
GENE (2001)
Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit
LP Degen et al.
GASTROENTEROLOGY (2001)